The draft guidance recommends the drugs, which are not licensed for everyone who has high cholesterol levels, only if they are provided at the discounted price agreed with the companies.
Patients with the heart rhythm disorder atrial fibrillation (AF) who were treated long term with the blood thinner, warfarin, may have higher rates of dementia, according to a recent study of more than 10,000 patients.
Allergan is the first company to launch a generic version of of this drug to customers in the U.S.
In recent years, it has become clear that the impact of epigenetics is more common and complex than previously suspected, underscoring the need to conduct in-depth studies of these mechanisms.
The swift response came hours after Paris-based Sanofi, France's biggest drugmaker, threatened Medivation's board members with possible removal if they won't discuss a deal.
More than 15 million Americans have prescriptions for so-called proton pump inhibitors (PPIs), which decrease gastric acid production and generally have been considered safe.
The new grant will enable Disney and his team to further investigate the manipulation of microRNAs.
The immune system appears to hamper an investigational vaccine from inducing antibodies that protect against HIV infection.
Lilly has received additional designations for olaratumab from the FDA.
Metformin's action is generally related to the release of glucose from the liver.
Scientists are trying to find new ways to produce the nutritional fatty acids.
Multiple myeloma affects more than 30,000 Americans each year and is slightly more prevalent in men than in women.
The therapy has the ability to cross the blood-brain barrier and directly targets motor neurons affected by SMARD1.
New federal rules announced Thursday have the potential to upend the multibillion-dollar electronic cigarette industry.
A new device that slowly releases eye medication may one day be a promising option for the many glaucoma patients who struggle with administering their own daily prescription eye drops.